title: Functional and molecular imaging: applications for diagnosis and staging of localised prostate cancer.
abstract: Prostate cancer is currently the most common solid organ cancer type among men in the Western world. Currently, all decision-making algorithms and nomograms rely on demographics, clinicopathological data and symptoms. Such an approach can easily miss significant cancers while detecting many insignificant cancers. In this review, novel functional and molecular imaging techniques used in the diagnosis and staging of localised prostate cancer and their effect on treatment decisions are discussed.
authors.affiliation: Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1088, USA. turkbeyi@mail.nih.gov
authors.forename: B
authors.initials: B
authors.lastname: Turkbey
authors.forename: E
authors.initials: E
authors.lastname: Mena
authors.forename: O
authors.initials: O
authors.lastname: Aras
authors.forename: B
authors.initials: B
authors.lastname: Garvey
authors.forename: K
authors.initials: K
authors.lastname: Grant
authors.forename: P L
authors.initials: PL
authors.lastname: Choyke
mesh_terms: D006801:Humans; D008297:Male; D057054:Molecular Imaging / Q000379:methods*; D009367:Neoplasm Staging; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000473:pathology; D011859:Radiography
keywords: Localization; MRI; PET/CT; prostate cancer; staging